Table 2.
Lp(a)† | LpPLA2 mass† |
LpPLA2 activity† |
LDL† | HDL† | TG† | CRP† | IL-6† | sCD14† | Fetuin-A‡ | FGF-23§ | Calcium‡ | Phosphate‡ | Vit. D‡ | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lp(a) | 1.000 | |||||||||||||
LpPLA2 mass | −0.014 | 1.000 | ||||||||||||
LpPLA2 activity | −0.036 | 0.534 | 1.000 | |||||||||||
LDL | 0.115 | 0.230 | 0.367 | 1.000 | ||||||||||
HDL | 0.054 | −0.106 | −0.320 | −0.007 | 1.000 | |||||||||
TG | −0.105 | 0.037 | 0.275 | 0.178 | −0.489 | 1.000 | ||||||||
CRP | 0.065 | 0.088 | −0.010 | 0.002 | −0.182 | 0.149 | 1.000 | |||||||
IL-6 | 0.055 | 0.096 | 0.040 | −0.087 | −0.233 | 0.092 | 0.520 | 1.000 | ||||||
sCD14 | 0.068 | 0.117 | 0.077 | 0.062 | −0.005 | 0.044 | 0.258 | 0.193 | 1.000 | |||||
Fetuin-A | −0.035 | 0.053 | 0.115 | 0.111 | −0.096 | 0.337 | −0.054 | −0.016 | 0.064 | 1.000 | ||||
FGF-23 | 0.075 | −0.089 | −0.101 | −0.066 | −0.064 | 0.115 | 0.170 | 0.170 | 0.279 | 0.124 | 1.000 | |||
Calcium | −0.013 | 0.015 | −0.002 | 0.182 | 0.137 | 0.104 | −0.057 | −0.019 | −0.034 | 0.049 | 0.098 | 1.000 | ||
Phosphate | 0.035 | −0.052 | −0.070 | 0.059 | 0.138 | 0.016 | 0.006 | −0.058 | 0.206 | 0.082 | 0.089 | 0.099 | 1.000 | |
Vit. D | 0.002 | −0.047 | 0.067 | −0.108 | 0.031 | 0.001 | −0.081 | −0.139 | −0.028 | 0.006 | −0.058 | 0.002 | 0.031 | 1.000 |
In subset of participants with at least one cardiac calcification measure.
1989 to 1990 for the original cohort and, 1992 to 1993 for the supplemental cohort.
1992 to 1993 for both cohorts, using baseline variables when variables from 1992 to 1993 were not available.
1996 to 1997 for both cohorts, using 1992 to 1993 and baseline variables when variables from 1996 to 1997 covariates were not available.
Abbreviations are as in Table 1. Vit. D = 25-hydroxyvitamin D